Hospitals Management Press Releases | Healthcare Industry Press Releases

Organ donation again sets record in 2019

9 January 2020

RICHMOND, Va., Jan. 9, 2020 /PRNewswire/ -- Nearly 11,900 people provided the lifesaving gift of organ donation upon their death last year, making 2019 the ninth consecutive record-breaking year for deceased donation in the United States. The 11,870 deceased donor total represents an increase of 10.7 percent over 2018, according to prelim

Cardinal Analytx Rebrands as Prealize to Reflect Power of Solution to Deliver Proactive Care by Turning Insights into Action

9 January 2020

PALO ALTO, Calif., Jan. 9, 2020 /PRNewswire/ -- Cardinal Analytx Solutions, an artificial intelligence (AI)-enabled health insights company, today announced that it has rebranded as Prealize.

Jorjin and Gigabyte Join Forces to Showcase a Smart Pharmacy Solution and a New Family of AR Smart Glasses at CES 2020

9 January 2020

LAS VEGAS, Jan. 9, 2020 /PRNewswire/ -- Jorjin Technologies, who started working on smart glasses when AR was still in its infancy, will be partnering with Gigabyte at this year's CES on a joint AR-based end-to-end solution for Smart Pharmacies. Furthermore, Jorjin will also introduce J-Ability, the c

Almirall signs a strategic agreement with 23andMe to license rights of a bispecific monoclonal antibody that blocks all three isoforms of IL-36 cytokine

9 January 2020

BARCELONA, Spain and SUNNYVALE, Calif., Jan. 9, 2020 /PRNewswire/ -- Almirall, S.A. (ALM), a leading global pharmaceutical company focused o

Almirall and WuXi Biologics Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases

9 January 2020

BARCELONA, Spain, Jan. 9, 2020 /PRNewswire/ -- Almirall, S.A. (ALM) and WuXi Biologics ("WuXi Bio") (2269.HK) have today announced the signing of an agreement. Through this coll

Almirall enters into an option agreement to acquire Bioniz Therapeutics and to establish a broad research agreement to further expand its innovative pipeline in medical dermatology

9 January 2020

BARCELONA, Spain, Jan. 9, 2020 /PRNewswire/ -- Almirall, S.A. (ALM) has announced today the execution of an option agreement to acquire Bioniz Therapeutics, Inc. a clinical stag

The American Heart Association (\"AHA\") Recognizes Mezzion\'s FUEL Trial as the Biggest Victory in Congenital Heart Disease (\"CHD\") Advancements for 2019

9 January 2020

DEERFIELD, Ill., Jan. 9, 2020 /PRNewswire/ -- Mezzion Pharma Co. Ltd. (140410: KOSDAQ) is pleased to announce that the AHA, one of the top funders of heart- and stroke-related research worldwide, selected Mezzion's FUEL Trial that concerns the treatment of single ventricle heart disease ("SVHD") adolescents who have undergone Fontan palliation with udenafil that showed i

Univfy to Speak at ACG New York Women of Leadership Summit and European HealthTech CEO Forum About Future of FemTech and HealthTech

9 January 2020

LOS ALTOS, Calif., Jan. 9, 2020 /PRNewswire/ -- Univfy, an AI platform company with a mission to expand access to in vitro fertilization (IVF), announced that cofounder and CEO M

Feeding America Food Bank Pilot Intervention Demonstrates Improved Outcomes for Adults with Prediabetes

9 January 2020

CHICAGO, Jan. 9, 2020 /PRNewswire/ -- A new study from Feeding America®, the nationwide network of 200 food banks and the largest domestic hunger-relief organization, shows that fo

Global Biotech Leader CSL to Present at 38th Annual J.P. Morgan Healthcare Conference

9 January 2020

KING OF PRUSSIA, Pa., Jan. 9, 2020 /PRNewswire/ -- Global biotechnology giant CSL Limited, parent company of biotherapeutics leader CSL Behring and world-leading influenza provider Seqirus, will present at the 38th annual J.P. Morgan Healthcare Conference in San Francisco. Chief Executive Officer and Managing Director